The usual treatment for an acute thromboembolism during the endovascular treatment of intracranial aneurysms includes the use of intra-arterial (IA) fibrinolytic agents or GP IIb/IIIa inhibitors [1,2,6,11]. This evidence concerns the gene ITGA2B and Dilatation of the cerebral artery.